79 results
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
15 May 24
Results of Operations and Financial Condition
4:34pm
21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. These include
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
5 Apr 24
Other Events
4:33pm
within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 (“PSLRA
8-K
EX-99.1
rndfxlcewry
29 Mar 24
Results of Operations and Financial Condition
8:35am
8-K
EX-10.1
6kh2dvq5j
18 Mar 24
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
d1v4l
17 Jan 24
Other Events
8:35am
8-K
EX-99.1
684iou4
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
EX-99.2
jfjcs8ovtkxz793ljc
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
EX-10.1
3injn37om
22 Dec 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-99.1
2accb2 pies
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K
EX-99.1
105 tzxc2pt4hw8
3 Nov 23
Other Events
5:10pm
8-K
EX-99.2
5p0l752b5u
27 Sep 23
Other Events
5:41pm
8-K
EX-99.1
cfn0u f6igpbxmr27jwr
27 Sep 23
Other Events
5:41pm
8-K
EX-99.1
3l2ghlz hdfwtd302t2
7 Sep 23
Other Events
8:00am
8-K/A
EX-99.1
l2mkbmf8
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.2
35fz4xdzjabu
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm